KLRS
#4131
Kalaris Therapeutics, Inc. - Common Stock
2.2 3 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.33%
Monthly Change
-34.60%
6 month change
-64.55%
Year Change
-78.20%
Previous Close
2.2 6
Open
2.2 7
Low
2.2 0
High
2.3 0
Financials
2023
Current report, Q2 FY2023
Kalaris Therapeutics, Inc. current report, Q2 FY2023
8-K
Current report, Q2 FY2023
Kalaris Therapeutics, Inc. current report, Q2 FY2023
8-K
Quarterly report, Q1 FY2023
Kalaris Therapeutics, Inc. quarterly report, Q1 FY2023
10-Q
Current report, Q1 FY2023
Kalaris Therapeutics, Inc. current report, Q1 FY2023
8-K
Current report, Q1 FY2023
Kalaris Therapeutics, Inc. current report, Q1 FY2023
8-K
Current report, Q1 FY2023
Kalaris Therapeutics, Inc. current report, Q1 FY2023
8-K
2022
Annual report, FY2022
Kalaris Therapeutics, Inc. annual report, FY2022
10-K
Current report, Q4 FY2022
Kalaris Therapeutics, Inc. current report, Q4 FY2022
8-K
Current report, Q4 FY2022
Kalaris Therapeutics, Inc. current report, Q4 FY2022
8-K
Quarterly report, Q3 FY2022
Kalaris Therapeutics, Inc. quarterly report, Q3 FY2022
10-Q